PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB WITH AND WITHOUT VIBOSTOLIMAB (ANTI-TIGIT) IN PATIENTS WITH PD-L1-POSITIVE METASTATIC NSCLC

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/47621

Title:	PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB WITH AND WITHOUT VIBOSTOLIMAB (ANTI-TIGIT) IN PATIENTS WITH PD-L1-POSITIVE METASTATIC NSCLC
Authors:	HELLMANN, Matthew; CHO, Byoung; JUERGENS, Rosalyn; CHENG, Ying; CASTRO, Gilberto de; ERMAN, Mustafa; BAUMAN, Jessica; TAKAHASHI, Toshiaki; SCHWARZENBERGER, Paul; ZHANG, Pingye; PIETANZA, M. Catherine; YANG, James Chih-Hsin
Citation:	JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A488-A488, 2021
Appears in Collections:	Comunicações em Eventos - FM/MDR Departamento de Radiologia - FM/MDR Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.